The Vox Markets Podcast / Cathal Friel & Jeremy Skillington of Poolbeg Pharma explain why they have listed on the OTCQB Venture Market in the US

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.